Strs Ohio Igm Biosciences, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$13.27 - $25.5 $69,004 - $132,600	5,200 New	5,200 $93,000
Q4 2021 Jan 24, 2022	SELL	$27.59 - $66.39 $110,360 - $265,560	-4,000 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$57.98 - $96.6 $63,778 - $106,260	-1,100 Reduced 21.57%	4,000 $332,000
Q3 2020 Dec 14, 2020	BUY	$43.0 - $84.01 $163,400 - $319,238	3,800 Added 292.31%	5,100 $376,000
Q4 2019 Jan 24, 2020	BUY	$17.25 - $49.51 $22,425 - $64,363	1,300 New	1,300 $49,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.